Decreased mitochondrial DNA content in blood samples of patients with stage I breast cancer
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Background: Alterations of mitochondrial DNA (mtDNA) have been implicated in carcinogenesis. We developed an accurate multiplex quantitative real-time PCR for synchronized determination of mtDNA and nuclear DNA (nDNA). We sought to investigate whether mtDNA content in the peripheral blood of breast cancer patients is associated with clinical and pathological parameters. Methods: Peripheral blood samples were collected from 60 patients with breast cancer and 51 age-matched healthy individuals as control. DNA was extracted from peripheral blood for the quantification of mtDNA and nDNA, using a one-step multiplex real-time PCR. A FAM labeled MGB probe and primers were used to amplify the mtDNA sequence of the ATP 8 gene, and a VIC labeled MGB probe and primers were employed to amplify the glyceraldehyde-3-phosphate-dehydrogenase gene. mtDNA content was correlated with tumor stage, menstruation status, and age of patients as well as lymph node status and the expression of estrogen receptor (ER), progesterone receptor (PR) and Her-2/neu protein. Results: The content of mtDNA in stage I breast cancer patients was significantly lower than in other stages (overall P = 0.023). Reduced mtDNA was found often in post menopausal cancer group (P = 0.024). No difference in mtDNA content, in regards to age (p = 0.564), lymph node involvement (p = 0.673), ER (p = 0.877), PR (p = 0.763), and Her-2/neu expression (p = 0.335), was observed. Conclusion: Early detection of breast cancer has proved difficult and current detection methods are inadequate. In the present study, decreased mtDNA content in the peripheral blood of patients with breast cancer was strongly associated with stage I. The use of mtDNA may have diagnostic value and further studies are required to validate it as a potential biomarker for early detection of breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Denko, N. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2468 · Cited by 1,707
Mitochondrial Fusion and Fission in Mammals
Chan, D. C. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010305.104638 · Cited by 972 · cited 1×
“Mitochondria play an essential role in cellular energy metabolism, free radical generation and programmed cell death [23].”
BackgroundBUFFENSTEIN, R. (1995) · Physiology & Behavior · doi:10.1016/0031-9384(95)02003-9 · Cited by 252 · cited 1×
“Several studies showed that mitochondria respiration varies during the menstrual cycle and is correlated with pregnancy[35,36].”
Background24-hour energy expenditure and the menstrual cycle
Webb, P. (1986) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/44.5.614 · Cited by 237 · cited 1×
“Several studies showed that mitochondria respiration varies during the menstrual cycle and is correlated with pregnancy[35,36].”
BackgroundBarrientos, A., Casademont, J., Cardellach, F., Estivill, X., Urbano-Marquez, A., & Nunes, V. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00278-7 · Cited by 149 · cited 1×
“reported that an increase in mtDNA content might be a compensatory response for decline in respiratory function [30].”
Background
Cited by
Is mitochondrial DNA content a potential biomarker of mitochondrial dysfunction?
Malik, A. N., & Czajka, A. (2013) · Mitochondrion · doi:10.1016/j.mito.2012.10.011 · Cited by 499
Potential biomarkers to follow the progression and treatment response of Huntington’s disease
Disatnik, M.-H., Joshi, A. U., Saw, N. L., Shamloo, M., Leavitt, B. R., Qi, X., & Mochly-Rosen, D. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20160776 · Cited by 58
“, 2013) and for diseases such as cancer and neurodegenerative diseases (Kohler et al., 2009; Xia et al., 2009a; Podlesniy et al., 2013).”
BackgroundMethodInfluentialPieters, N., Janssen, B. G., Valeri, L., Cox, B., Cuypers, A., Dewitte, H., Plusquin, M., Smeets, K., & Nawrot, T. S. (2015) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2015.02.003 · Cited by 43
Clinical significance of serum mitochondrial DNA in lung cancer
Hou, Y.-L., Chen, J.-J., Wu, Y.-F., Xue, C.-J., Li, F.-Z., Zheng, Q., & Chen, H. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.04.009 · Cited by 13
Metadata
- Authors
- Xia, P., An, H.-X., Dang, C.-X., Radpour, R., Kohler, C., Fokas, E., Engenhart-Cabillic, R., Holzgreve, W., & Zhong, X. Y.
- Venue
- BMC Cancer
- Published
- 2009-12
- Volume
- 9
- Issue
- 1
- Pages
- 454-454
- ISSN
- 1471-2407 (ISSN-L)
- OpenAlex
- W2000289869
- Cited by
- 94
- References
- 5
- FWCI
- 1.92
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Decreased mitochondrial DNA content in blood samples of patients with stage I breast cancer. https://app.cochat.ai/papers/10.1186/1471-2407-9-454
- The paper
- Xia, P., An, H.-X., Dang, C.-X., Radpour, R., Kohler, C., Fokas, E., Engenhart-Cabillic, R., Holzgreve, W., & Zhong, X. Y. (2009). Decreased mitochondrial DNA content in blood samples of patients with stage I breast cancer. BMC Cancer. https://doi.org/10.1186/1471-2407-9-454
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.